Table 4.
Comparison of antibiotic resistance of ESBL-producing and -nonproducing strains
| Antibiotics | ESBL-producing strains (n=9)
|
Non-ESBL-producing strains (n=8)
|
||
|---|---|---|---|---|
| S | I+R (%) | S | I+R (%) | |
|
| ||||
| Ceftazidime | 1 | 8 (88.9) | 6 | 2 (25.0) |
| Cefoperazone | 0 | 9 (100) | 5 | 3 (37.5) |
| Cefotaxime | 0 | 9 (100) | 4 | 4 (50.0) |
| Ciprofloxacin | 2 | 7 (77.8) | 7 | 1 (12.5) |
| Cefoxitin | 7 | 2 (22.2) | 4 | 4 (50.0) |
| Cefepime | 2 | 7 (77.8) | 7 | 1 (12.5) |
| Piperacillin/tazobactam sodium | 8 | 1 (11.1) | 7 | 1 (12.5) |
| Ticarcillin/clavulanic acid | 0 | 9 (100) | 4 | 4 (50.0) |
| Cefoperazone/sulbactam | 5 | 4 (44.4) | 6 | 2 (25.0) |
| Imipenem | 9 | 0 (0) | 7 | 1 (12.5) |
Abbreviations: ESBL, extended-spectrum β lactamase; I, intermediate; R, resistant; S, sensitive.